Black Diamond Therapeutics Inc (BDTX) — Financial Flexibility Index
Black Diamond Therapeutics Inc (BDTX) has a Financial Flexibility Index of -0.36x as of March 2026. Free cash flow of $-10.23 Million (operating CF $-10.23 Million minus capex $0.00) represents 0% of total liabilities ($28.62 Million). Also explore net asset momentum of Black Diamond Therapeutics Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Black Diamond Therapeutics Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Black Diamond Therapeutics Inc across 9 annual periods. Check BDTX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Black Diamond Therapeutics Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Black Diamond Therapeutics Inc. For the full company profile including market capitalisation, see Black Diamond Therapeutics Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | $29.61 Million | $29.61 Million | $30.80 Million | ▲ +160.7% |
| 2024 | -1.58x | $-62.30 Million | $-62.30 Million | $39.35 Million | ▲ +0.7% |
| 2023 | -1.59x | $-66.68 Million | $-66.72 Million | $41.83 Million | ▲ +23.8% |
| 2022 | -2.09x | $-84.89 Million | $-85.08 Million | $40.56 Million | ▼ -11.2% |
| 2021 | -1.88x | $-97.44 Million | $-100.15 Million | $51.78 Million | ▲ +20.7% |
| 2020 | -2.37x | $-52.00 Million | $-52.15 Million | $21.91 Million | ▼ -1877.9% |
| 2019 | -0.12x | $-24.65 Million | $-24.67 Million | $205.45 Million | ▲ +3.5% |
| 2018 | -0.12x | $-8.38 Million | $-8.45 Million | $67.37 Million | ▲ +19.6% |
| 2017 | -0.15x | $-2.27 Million | $-2.35 Million | $14.70 Million | — |